Sonoma Pharmaceuticals Inc (SNOA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Sonoma Pharmaceuticals Inc

Healthcare (1051)

800-759-9305

5445 CONESTOGA COURT, SUITE 150, BOULDER, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SNOA's Discussions on Twitter

Compare SNOA vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SNOA Sonoma Pharmaceuticals Inc	1.15	5.51M	19.53M	-3.18M	-4.13M	-1.888
TAK Takeda Pharmaceutical Co Adr	19.45	62.13B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.11	47.95B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.94	43.71B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	78.42	32.40B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	541.51	23.23B	3.17B	1.29B	1.01B	27.09

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Compare SNOA vs TAK, TEVA, HLN, ZTS, UTHR

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

Reviva Pharmaceuticals Holdings (OTCPK:RVPH)Stock Analysis - Simply Wall Street

Kazia Therapeutics Limited (KZIA) stock price, news, quote and history - Yahoo Finance Singapore

Williams-Sonoma CFO Jeffrey Howie Sells 3,045 Shares - Yahoo Finance

Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Resistance at $1.32SuperTrend - siam.in

Williams-Sonoma, Inc. declares quarterly cash dividend - Yahoo Finance

Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Resistance at $1.32Stock Surge Alerts - dars.gov.et

Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportHagopian Line - siam.in

Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportBollinger Squeeze - careplusvn.com

Sonoma Pharmaceuticals (SNOA) Ticks Up to $1.31, Holding Above Key SupportNHNL Ratio - dars.gov.et

Sonoma Pharmaceuticals Stock Price Forecast. Should You Buy SNOA? - StockInvest.us

Sonoma (SNOA) Market: Holds Near $1.34 in the Available Record; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayIV Contraction - vinanet.vn

Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayMid Cap Momentum - vinanet.vn

Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayPut Dominated - vinanet.vn

Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayOverbought Signal Alerts - siam.in

Sonoma (SNOA) Shares: Holds Near $1.34 at the Close; Technical View: the Session Ends Within the Reported Technical Boundaries in Latest TradingBear Flag - vinanet.vn

Sonoma (SNOA) Shares: Holds Near $1.34 at the Close; Technical View: the Session Ends Within the Reported Technical Boundaries in Latest TradingPrice Surge Stocks - siam.in

Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com Nigeria

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com South Africa

Sonoma Pharmaceuticals Cancels Adjourned Special Stockholder Meeting - TipRanks

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com Canada

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum - Investing.com

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com UK

Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com Canada

Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com India

Price to earnings forward of Sonoma Pharmaceuticals, Inc. – SWB:O8Z - TradingView

WEBTOON (WBTN) Earnings Brief: EPS Clears the Reported Estimate in the Latest Session; Trading Response: Shares Finish 1.90% Down on the DayEarnings Decline Risk - www.dars.gov.et

Pagaya Technologies Warrants (PGYWW) Drop 7.02% to $0.03 as Trading Remains Pinned at Penny LevelETF Outflow Streak - dars.gov.et

Sonoma Pharmaceuticals reports 60% revenue growth in Q1 By Investing.com - Investing.com Nigeria

Sonoma Pharmaceuticals reports 60% revenue growth in Q1 - Investing.com

Sonoma FY2027 Q1 earnings: 60% revenue growth moves EBITDA positive - TradingKey

Sonoma Pharmaceuticals reports 60% revenue growth in Q1 By Investing.com - Investing.com Canada

Sonoma Pharmaceuticals Q1 revenue rises on US growth - TradingView

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Bay to Bay News

BRIEF-Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million - TradingView

Sonoma U.S. Revenue Climbs 141%; First-Ever Positive Adjusted EBITDA - Stock Titan

Sonoma Pharmaceuticals, Inc. Q1 2027: Revenue $6.41M, EPS $(0.09) — 10-Q Summary - TradingView

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue - TradingView

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - ACCESS Newswire

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Yahoo Finance

Sonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level LoomsStop Loss Guidance - dars.gov.et

SNOA Q1'26 Earnings: EPS estimate is (0.30) USD - TradingView

Sonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level LoomsBreak of Structure - vinanet.vn

SNOA Q2 2026 Earnings: Narrow EPS Miss Weighs on SharesROE Trend Analysis - vinanet.vn

SNOA Q2 2026 Earnings: Narrow EPS Miss Weighs on SharesEarnings Revision Upgrade - dars.gov.et

Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July By Investing.com - Investing.com Nigeria

Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July By Investing.com - Investing.com South Africa

Sonoma Pharmaceuticals (SNOA) Hovers Near Support as Slight Decline ContinuesEarnings Miss Risk - dars.gov.et

Sonoma Pharmaceuticals (SNOA) Hovers Near Support as Slight Decline ContinuesRVOL Breakout - vinanet.vn

Sonoma Pharmaceuticals Inc (SNOA) Institutional Confidence - TradingKey

Sonoma Pharmaceuticals Inc (SNOA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SNOA